Chronic renal failure after transplantation of a nonrenal organ.
By A. Ojo, P. Held, F. Port, R. Wolfe, A. Leichtman, E. Young, J. Arndorfer, L. Christensen, R. Merion. New England Journal of Medicine, 2003
2,016 citations recorded by the source corpus.
Subfields: Public Health, Environmental and Occupational Health, Surgery, Transplantation
View Paper: https://www.semanticscholar.org/paper/0f21606997e376d929c11ec6a14cae037f80109c
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- P. Burra
- J. Valdecasas
- D. Samuel
- J. Pirenne
- RS Brown
- JB Wong
- NA Terrault
- M. Jonas
Citations in the corpus
- Update on Prevention, Diagnosis, and Treatment and of Chronic Hepatitis B: AASLD 2018 Hepatitis B Guidance (2018, background): “Tenofovir alafenamide or entecavir are preferred in patients who are at higher risk of renal disease.((261))”
- EASL Clinical Practice Guidelines: Liver transplantation. (2016, background): “Between 30–80% of patients develop chronic kidney disease stage 3–4 with a cumulative risk of ESRD requiring maintenance dialysis or even renal transplantation of 5–9% within the first 10 years post-LT [295,430].”